Chronic lymphocytic leukemia (CLL) is one of the most common blood cancers in adults. The disease originates in B cells—the part of the immune system that produces antibodies—and then evolves slowly, typically affecting ...
Apr 21, 2022
0
38
A discovery by researchers at the University of Sussex has the potential to benefit leukemia patients by opening up new treatment strategies for treating the disease.
Apr 21, 2022
0
15
A new study published today in the journal Genes & Development reveals a gene that normally suppresses the formation of tumors but is reprogrammed at the onset of acute promyelocytic leukemia (APL), an aggressive type of ...
Apr 20, 2022
0
41
Researchers from Barts Cancer Institute at Queen Mary University of London have identified a way to reverse resistance to a group of cancer drugs, known as kinase inhibitors, in leukemia cells. By rewiring the inner workings ...
Apr 19, 2022
0
74
For patients with acute lymphoblastic leukemia with resistance to C19 CAR T-cell therapy, resistance mechanisms that can be detected prior to treatment have been identified, according to a study presented at the annual meeting ...
Apr 12, 2022
0
12
Some Latino children diagnosed with acute lymphoblastic leukemia (ALL) were more likely to experience relapse than non-Hispanic white children, according to data presented at the AACR Annual Meeting 2022, held April 8-13. ...
Apr 12, 2022
0
5
Acute lymphoblastic leukemia (ALL) cells from patients whose cancers did not respond to CD19-targeted CAR T therapy had gene regulation signatures that could potentially facilitate treatment resistance, according to results ...
Apr 12, 2022
0
2
During the first nine months of the COVID-19 pandemic, pediatric cancer patients from lower- and middle-income countries faced a higher risk of all-cause mortality than those in high-income countries, according to data presented ...
Apr 11, 2022
0
54
According to the latest international assessment, one in two persons will develop cancer at some point in their life. Blood cancers and other previously rare cancer types are also becoming increasingly common in the population. ...
Apr 11, 2022
0
19
Using the nation's largest COVID-19 data resource, a researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center found the COVID-19 vaccine protected most cancer patients from getting COVID. However, ...
Apr 4, 2022
0
62
